2018 New You Beauty Awards - Powered by OmegaXL

Tennis Champ Maria Sharapova Fails Drug Test

By Dontaira Terrell
Posted On Mar 08, 2016
Tennis Champ Maria Sharapova Fails Drug Test

Last night the Internet went into a frenzy after learning of the news that tennis star Maria Sharapova failed a drug test at this year’s, Australian Open. During a press conference, the Grand Slam winner admitted, she tested positive for meldonium and had been informed by the International Tennis Federation of the results.


According to the U.S. National Library of Medicine, meldonium, also referred to as mildronate, is used to treat brain circulation disorders, serious heart conditions, and helps prevent ischemia which is a vascular disease that can ultimately lead to tissue death. Additionally, the drug also allows individuals to, “become more active, their motor dysfunction decreases, and asthenia, dizziness and nausea become less pronounced,” which also grants a drastic change in a person’s mood.


In an official announcement, Sharapova had this to say, “I take full responsibility for it. I made a huge mistake. I let my fans down. I let my sport down. I don’t want to end my career this way… I know many of you thought I was retiring. But if I was ever going to announce my retirement, it would not be in this downtown Los Angeles hotel with this fairly ugly carpet.”


Due to a magnesium deficiency and a long family lineage of diabetes, the medication had been prescribed to the tennis champ by a doctor. This particular drug had not been included on the banned list for the last decade but unfortunately the rules changed as of January 1st of this year. You can check out the video below of Maria Sharapova’s shocking admission during yesterday’s press conference.